Vinci Gen S.A. (WSE:VGN)
Poland · Delayed Price · Currency is PLN 0.4100
0.00 (0.00%)
At close: Aug 1, 2025
Vinci Gen Company Description
Vinci Gen S.A. engages in the building and development of an integrated ecosystem of health services using modern genetics and imaging diagnostics in Poland, the European Union and global markets.
Its areas of activity are NIPT prenatal diagnostics, genetic cancer diagnostics, artificial intelligence in diagnostics, telemedicine and mobile applications, medical marijuana and supportive therapies, and translational medicine and scientific cooperation.
Vinci Gen S.A. was formerly known as Movie Games VR Spólka Akcyjna and changed its name to Vinci Gen S.A. in July 2025.
Vinci Gen S.A. was incorporated in 2010 and is headquartered in Warsaw, Poland.
Vinci Gen S.A.
| Country | Poland |
| Founded | 2010 |
| Industry | Management Consulting Services |
| Employees | 1 |
| CEO | Michal Marczuk |
Contact Details
Address: ul. Krucza 16/22 Warsaw, 00-526 Poland | |
| Website | ipo.com.pl |
Stock Details
| Ticker Symbol | VGN |
| Exchange | Warsaw Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | PLN |
| SIC Code | 8742 |
Key Executives
| Name | Position |
|---|---|
| Michal Marczuk | Chief Executive Officer |